Subtyping Pancreatic Cancer

被引：35
|
作者：
Biankin, Andrew V. [1 ,2 ,3 ,4 ]
Maitra, Anirban [5 ]
机构：
[1] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Glasgow G61 1BD, Lanark, Scotland
[2] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G31 2ER, Lanark, Scotland
[3] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Div, Sydney, NSW 2010, Australia
[4] Univ NSW, Fac Med, South Western Sydney Clin Sch, Liverpool, NSW 2170, Australia
[5] Univ Texas MD Anderson Canc Ctr, Sheikh Ahmed Ctr Pancreat Canc Res, Pathol & Translat Mol Pathol, Houston, TX 77030 USA
来源：
CANCER CELL | 2015年 / 28卷 / 04期
基金：
英国惠康基金;
关键词：
THERAPY;
D O I：
10.1016/j.ccell.2015.09.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The complex tumor microenvironment can make molecularly subtyping cancer using mRNA expression challenging, particularly for cancers with low epithelial content, such as pancreatic cancer. In a recent edition of Nature Genetics, Moffitt and colleagues show that subtracting normal epithelial transcripts can provide insights into the molecular pathology of pancreatic cancer.
引用
收藏
页码：411 / 413
页数：4
相关论文
共 50 条
  • [41] Molecular subtyping of small cell lung cancer
    Liang, Jie
    Guan, Xiaojiao
    Bao, Guangyao
    Yao, Yao
    Zhong, Xinwen
    [J]. SEMINARS IN CANCER BIOLOGY, 2022, 86 : 450 - 462
  • [42] Molecular subtyping of breast cancer: ready to use?
    de Ronde, Jorma
    Wessels, Lodewyk
    Wesseling, Jelle
    [J]. LANCET ONCOLOGY, 2010, 11 (04): : 306 - 307
  • [43] RT LAMP assay for the subtyping of breast cancer
    Lee, In Hee
    Kang, Byeongju
    Lee, Jeeyeon
    Jung, Jin Hyang
    Park, Ho Yong
    Park, Nora Jee-Young
    Park, Ji-Young
    Kim, Eun Ae
    Kang, Jieun
    Chae, Yee Soo
    Lee, Soo Jung
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [44] Breast cancer subtyping from plasma proteins
    Fan Zhang
    Jake Y Chen
    [J]. BMC Medical Genomics, 6
  • [45] Breast cancer subtyping from plasma proteins
    Zhang, Fan
    Chen, Jake Y.
    [J]. BMC MEDICAL GENOMICS, 2013, 6
  • [46] Introducing Molecular Subtyping of Breast Cancer Into the Clinic?
    Sorlie, Therese
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (08) : 1153 - 1154
  • [47] Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen
    Pino G. Cusumano
    Kenneth Deck
    Deborah Kerlin
    Agustin A. Garcia
    Julie L. Barone
    Edgardo Rivera
    Katharine Yao
    Femke A. de Snoo
    Jeroen van den Akker
    Lisette Stork-Sloots
    Daniele Generali
    [J]. Annals of Surgical Oncology, 2012, 19 : 3257 - 3263
  • [48] Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients
    Bichlien Nguyen
    Cusumano, Pino G.
    Deck, Kenneth
    Kerlin, Deborah
    Garcia, Agustin A.
    Barone, Julie L.
    Rivera, Edgardo
    Yao, Katharine
    de Snoo, Femke A.
    van den Akker, Jeroen
    Stork-Sloots, Lisette
    Generali, Daniele
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (10) : 3257 - 3263
  • [49] Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact
    Roesli, Christoph
    [J]. EXPERT REVIEW OF PROTEOMICS, 2015, 12 (01) : 5 - 8
  • [50] Traditional Classification and Novel Subtyping Systems for Bladder Cancer
    Zhu, Shaoming
    Yu, Weimin
    Yang, Xiao
    Wu, Cheng
    Cheng, Fan
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
12345